BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 5411984)

  • 1. Influence of heparin on the removal of serum lipoprotein lipase by the perfused liver of the rat.
    Naito C; Felts JM
    J Lipid Res; 1970 Jan; 11(1):48-53. PubMed ID: 5411984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heparin-decasaccharides impair the catabolism of chylomicrons.
    Chevreuil O; Hultin M; Ostergaard P; Olivecrona T
    Biochem J; 1996 Dec; 320 ( Pt 2)(Pt 2):437-44. PubMed ID: 8973550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of heparin on the inactivation of serum lipoprotein lipase by the liver in unanesthetized dogs.
    Whayne TF; Felts JM; Harris PA
    J Clin Invest; 1969 Jul; 48(7):1246-51. PubMed ID: 5794247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-Mr heparin is as potent as conventional heparin in releasing lipoprotein lipase, but is less effective in preventing hepatic clearance of the enzyme.
    Liu GQ; Bengtsson-Olivecrona G; Ostergaard P; Olivecrona T
    Biochem J; 1991 Feb; 273 ( Pt 3)(Pt 3):747-52. PubMed ID: 1996970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of size-fractionated heparins with lipoprotein lipase and hepatic lipase in the rat.
    Liu G; Hultin M; Ostergaard P; Olivecrona T
    Biochem J; 1992 Aug; 285 ( Pt 3)(Pt 3):731-6. PubMed ID: 1497611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rat liver contains a limited number of binding sites for hepatic lipase.
    Schoonderwoerd K; Verhoeven AJ; Jansen H
    Biochem J; 1994 Sep; 302 ( Pt 3)(Pt 3):717-22. PubMed ID: 7945195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunochemical assay of rat postheparin plasma triacylglycerol lipases.
    Kuusi T; Ehnholm C; Nikkilä EA
    Atherosclerosis; 1980 Apr; 35(4):363-74. PubMed ID: 6990938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postheparin plasma lipoprotein lipase and hepatic lipase in diabetes mellitus. Relationship to plasma triglyceride metabolism.
    Nikkilä EA; Huttunen JK; Ehnholm C
    Diabetes; 1977 Jan; 26(1):11-21. PubMed ID: 187516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential effects of streptozotocin-induced diabetes on cardiac lipoprotein lipase activity.
    Rodrigues B; Cam MC; Jian K; Lim F; Sambandam N; Shepherd G
    Diabetes; 1997 Aug; 46(8):1346-53. PubMed ID: 9231661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preferential clearance of apoB-48-containing lipoproteins after heparin-induced lipolysis is modulated by lipoprotein lipase activity.
    van Beek AP; van Barlingen HH; de Ruijter-Heijstek FC; Jansen H; Erkelens DW; Dallinga-Thie GM; de Bruin TW
    J Lipid Res; 1998 Feb; 39(2):322-32. PubMed ID: 9507993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Uptake of hypertriglyceridemic very low density lipoproteins and their remnants by HepG2 cells: the role of lipoprotein lipase, hepatic triglyceride lipase, and cell surface proteoglycans.
    Huff MW; Miller DB; Wolfe BM; Connelly PW; Sawyez CG
    J Lipid Res; 1997 Jul; 38(7):1318-33. PubMed ID: 9254059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipoprotein lipase release from cardiac myocytes is increased by decavanadate but not insulin.
    Braun JE; Severson DL
    Am J Physiol; 1992 May; 262(5 Pt 1):E663-70. PubMed ID: 1590376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Free fatty acids do not release lipoprotein lipase from isolated cardiac myocytes or perfused hearts.
    Rodrigues B; Spooner M; Severson DL
    Am J Physiol; 1992 Feb; 262(2 Pt 1):E216-23. PubMed ID: 1539648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myocardial lipoprotein lipase activity: regulation by diabetes and fructose-induced hypertriglyceridemia.
    Liu L; Severson DL
    Can J Physiol Pharmacol; 1995 Mar; 73(3):369-77. PubMed ID: 7648516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipoprotein lipase enables triacylglycerol hydrolysis by perfused newborn rat liver.
    Giménez-Llort L; Vilanova J; Skottova N; Bengtsson-Olivecrona G; Llobera M; Robert MQ
    Am J Physiol; 1991 Oct; 261(4 Pt 1):G641-7. PubMed ID: 1928350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Depletion of lipoprotein lipase after heparin administration.
    Chevreuil O; Hultin M; Ostergaard P; Olivecrona T
    Arterioscler Thromb; 1993 Oct; 13(10):1391-6. PubMed ID: 8399074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sex- and age-related variations in the in vitro heparin-releasable lipoprotein lipase from mononuclear leukocytes in blood.
    Maehira F; Miyagi I; Eguchi Y
    Biochim Biophys Acta; 1990 Feb; 1042(3):344-51. PubMed ID: 2106346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of heparin-releasable lipase and tissue neutral lipase activity of rat heart.
    Stam H; Hülsmann WC
    Biochem Int; 1983 Aug; 7(2):187-95. PubMed ID: 6679339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of heparin on the uptake of lipoprotein lipase in rat liver.
    Neuger L; Vilaró S; Lopez-Iglesias C; Gupta J; Olivecrona T; Olivecrona G
    BMC Physiol; 2004 Nov; 4(1):13. PubMed ID: 15544705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolism of VLDL is increased in streptozotocin-induced diabetic rat hearts.
    Sambandam N; Abrahani MA; Craig S; Al-Atar O; Jeon E; Rodrigues B
    Am J Physiol Heart Circ Physiol; 2000 Jun; 278(6):H1874-82. PubMed ID: 10843884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.